Harvard Medical School - Massachusetts General Hospital (USA)
hôte : Nathalie Bonnefoy & Maeva Chauvin (IRCM)
Pr. David Pépin, Ph.D., is an Associate Professor of Surgery at Harvard Medical School and Massachusetts General Hospital. He trained as a molecular and developmental biologist, earning his doctorate at the University of Ottawa and completing postdoctoral training in reproductive biology and ovarian cancer research at MGH. His laboratory is focused on women’s health, from fertility to ovarian cancer. His team has pioneered research on the role of developmental hormone signals, such as anti?Müllerian hormone (AMH), in regulating the tumor microenvironment through stromal cells such as cancer?associated mesothelial cells (CAMCs). Pr. Pépin’s work combines advanced preclinical models and biological insights to uncover novel therapeutic targets for ovarian cancer and women’s health, bridging basic science with clinical applications.
Situé dans le Parc Euromédecine, l'Institut de Recherche en Cancérologie de Montpellier (U1194) est localisé sur le Campus Val d'Aurelle (ICM, Institut régional du Cancer Montpellier / Val d'Aurelle).
Centre de Recherche U1194 soutenu par l'Inserm, l'Université de Montpellier et l'Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de
